IP Library Granted Patent US 7,892,284
Granted Patent B2
US 7,892,284 · App. 11/885,221 · Granted Feb 22, 2011

Intraocular lens and process for producing the same

Assignee: Hoya Corporation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,892,284
App. No.
11/885,221
Granted
Feb 22, 2011
Kind
B2
Abstract

Provided is an intraocular lens that inhibits secondary cataract which occurs after insertion of an intraocular lens and that is free from the adherence and deposition of a protein, etc., to/on the front surface of the lens, and the intraocular lens has an optic portion with a front surface and a back surface, said front surface and said back surface being different from each other in the property of adhering to a protein and satisfying the relationship of the expression (x), PA F <PA B   (x) wherein PA F is the property of adherence of said front surface to fibronectin and PA B is the property of adherence of said back surface to fibronectin in a fibronectin adherence test.

Claims (36)

1. An intraocular lens having an optic portion having a front surface and a back surface and both the front surface and the back surface are surface treated, the front surface is surface-treated to inhibit the property of adhering to a protein, and the back surface is surface-treated to improve the property of adhering to a protein, said front surface and said back surface being different from each other in the property of adhering to a protein and satisfying the relationship of the expression (x),

PA F <PA B   (x)

wherein PA F is the property of adherence of said front surface to fibronectin and PA B is the property of adherence of said back surface to fibronectin in a fibronectin adherence test,

wherein the optic portion is formed of one piece,

wherein the front surface of the optic portion is a surface-treated front surface coated with a copolymer having a recurring unit of the general formula (I),

wherein R 1 is a hydrogen atom or an alkyl group having 1 to 4 carbon atoms, R 2 is a hydrogen atom, a hydroxyl group, a hydrocarbyloxy group, —Si(OR 4 ) 3 in which R 4 is a lower alkyl group or trimethylsilyl, or a group represented by

in which R 5 is methyl, phenyl or trimethylsiloxy and m is an integer of 1 to 100,

R 3 is an alkylene group, a is 0.03 to 0.70, b is 0.30 to 0.97 and n is an integer of 2 or more,

and having a number average molecular weight of 5,000 or more, the copolymer having been obtained from 2-methacryloyloxyethyl phosphorylcholine and (meth)acrylic ester.

2. An intraocular lens having an optic portion having a front surface and a back surface and both the front surface and the back surface are surface treated, the front surface is surface-treated to inhibit the property of adhering to a protein, and the back surface is surface-treated to improve the property of adhering to a protein, said front surface and said back surface being different from each other in the property of adhering to a protein and satisfying the relationship of the expression (x),

PA F <PA B   (x)

wherein PA F is the property of adherence of said front surface to fibronectin and PA B is the property of adherence of said back surface to fibronectin in a fibronectin adherence test,

wherein the optic portion is formed of one piece,

wherein the front surface of the optic portion is a surface-treated front surface coated with a copolymer having a recurring unit of the general formula (I),

wherein R 1 is a hydrogen atom or an alkyl group having 1 to 4 carbon atoms, R 2 is a hydrogen atom, a hydroxyl group, a hydrocarbyloxy group, —Si(OR 4 ) 3 in which R 4 is a lower alkyl group or trimethylsilyl, or a group represented by

in which R 5 is methyl, phenyl or trimethylsiloxy and m is an integer of 1 to 100,

R 3 is an alkylene group, a is 0.03 to 0.70, b is 0.30 to 0.97 and n is an integer of 2 or more,

and having a number average molecular weight of 5,000 or more, the copolymer having been obtained from 2-methacryloyloxyethyl phosphorylcholine and (meth)acrylic ester, and

the back surface of the optic portion is surface-treated by plasma treatment and/or by applying active light that works to decompose oxygen molecules to generate ozone and works to decompose said ozone to generate active oxygen in the presence of oxygen.

3. A process for producing the intraocular lens recited in claim 1 , which comprises coating the front surface of an optic portion with a copolymer having a recurring unit of the general formula (I),

wherein R 1 is a hydrogen atom or an alkyl group having 1 to 4 carbon atoms, R 2 is a hydrogen atom, a hydroxyl group, a hydrocarbyloxy group, —Si(OR 4 ) 3 in which R 4 is a lower alkyl group or trimethylsilyl, or a group represented by

in which R 5 is methyl, phenyl or trimethylsiloxy and m is an integer of 1 to 100,

R 3 is an alkylene group, a is 0.03 to 0.70, b is 0.30 to 0.97 and n is an integer of 2 or more,

and having a number average molecular weight of 5,000 or more, the copolymer having been obtained from 2-methacryloyloxyethyl phosphorylcholine and (meth)acrylic ester, thereby to surface-treat the front surface of the optic portion.

4. A process for producing the intraocular lens recited in claim 2 , which comprises surface-treating the front surface of an optic portion with a copolymer having a recurring unit of said general formula (I),

wherein R 1 is a hydrogen atom or an alkyl group having 1 to 4 carbon atoms, R 2 is a hydrogen atom, a hydroxyl group, a hydrocarbyloxy group, —Si(OR 4 ) 3 in which R 4 is a lower alkyl group or trimethylsilyl, or a group represented by

in which R 5 is methyl, phenyl or trimethylsiloxy and m is an integer of 1 to 100,

R 3 is an alkylene group, a is 0.03 to 0.70, b is 0.30 to 0.97 and n is an integer of 2 or more,

and having a number average molecular weight of 5,000 or more, the copolymer having been obtained from 2-methacryloyloxyethyl phosphorylcholine and (meth)acrylic ester, and

surface-treating the back surface of the optic portion by plasma treatment and/or by applying active light that works to decompose oxygen molecules to generate ozone and works to decompose said ozone to generate active oxygen in the presence of oxygen.

5. A process for producing the intraocular lens recited in claim 2 , which comprises surface-treating the front surface and back surface of an optic portion with a copolymer having a recurring unit of said general formula (I),

wherein R 1 is a hydrogen atom or an alkyl group having 1 to 4 carbon atoms, R 2 is a hydrogen atom, a hydroxyl group, a hydrocarbyloxy group, —Si(OR 4 ) 3 in which R 4 is a lower alkyl group or trimethylsilyl, or a group represented by

in which R 5 is methyl, phenyl or trimethylsiloxy and m is an integer of 1 to 100,

R 3 is an alkylene group, a is 0.03 to 0.70, b is 0.30 to 0.97 and n is an integer of 2 or more,

and having a number average molecular weight of 5,000 or more, the copolymer having been obtained from 2-methacryloyloxyethyl phosphorylcholine and (meth)acrylic ester, and

surface-treating the back surface of the optic portion by plasma treatment and/or by applying active light that works to decompose oxygen molecules to generate ozone and works to decompose said ozone to generate active oxygen in the presence of oxygen.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 22, 2024
From: HOYA CORPORATION
To: HOYA MEDICAL SINGAPORE PTE. LTD.
Reel/Frame 069753/0200 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 11, 2007
From: IWAMOTO, HIDETOSHI
To: HOYA CORPORATION
Reel/Frame 019860/0049 →
Priority Claims (1)
JP 2005-054421 · Feb 28, 2005 · national
Continuity (1)
Related Publication 20080177384A1 · Jul 24, 2008